Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Chronobiology and Chronopharmacology to Prevent Sickle Cell Kidney Disease

NCT02373241 is registered in ClinicalTrials.gov with University of Alabama at Birmingham as lead sponsor.

NCT NCT02373241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02373241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Chronobiology and Chronopharmacology to Prevent Sickle Cell Kidney Disease
Lead sponsor
University of Alabama at Birmingham
Phase
Phase 2
Overall status
Terminated
Start date
April 30, 2015
Completion date
July 31, 2021
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anemia, sickle cell, hypertension, kidney disease, proteinuria, sickle cell disease